Literature DB >> 17347991

Automated tissue segmentation and blind recovery of (1)H MRS imaging spectral patterns of normal and diseased human brain.

Shuyan Du1, Xiangling Mao, Paul Sajda, Dikoma C Shungu.   

Abstract

Constrained non-negative matrix factorization (cNMF) with iterative data selection is described and demonstrated as a data analysis method for fast and automatic recovery of biochemically meaningful and diagnostically specific spectral patterns of the human brain from (1)H MRS imaging ((1)H MRSI) data. To achieve this goal, cNMF decomposes in vivo multidimensional (1)H MRSI data into two non-negative matrices representing (a) the underlying tissue-specific spectral patterns and (b) the spatial distribution of the corresponding metabolite concentrations. Central to the proposed approach is automatic iterative data selection which uses prior knowledge about the spatial distribution of the spectra to remove voxels that are due to artifacts and undesired metabolites/tissues such as the strong lipid and water components. The automatic recovery of diagnostic spectral patterns is demonstrated for long-TE (1)H MRSI data on normal human brain, multiple sclerosis, and serial brain tumor. The results show the ability of cNMF with iterative data selection to automatically and simultaneously recover tissue-specific spectral patterns and achieve segmentation of normal and diseased human brain tissue, concomitant with simplification of information content. These features of cNMF, which permit rapid recovery, reduction and interpretation of the complex diagnostic information content of large multi-dimensional spectroscopic imaging data sets, have the potential to enhance the clinical utility of in vivo(1)H MRSI.

Entities:  

Mesh:

Year:  2008        PMID: 17347991     DOI: 10.1002/nbm.1151

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  5 in total

Review 1.  Methodological consensus on clinical proton MRS of the brain: Review and recommendations.

Authors:  Martin Wilson; Ovidiu Andronesi; Peter B Barker; Robert Bartha; Alberto Bizzi; Patrick J Bolan; Kevin M Brindle; In-Young Choi; Cristina Cudalbu; Ulrike Dydak; Uzay E Emir; Ramon G Gonzalez; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Petra S Huppi; Ralph E Hurd; Kejal Kantarci; Risto A Kauppinen; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Małgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Paul G Mullins; James B Murdoch; Sarah J Nelson; Ralph Noeske; Gülin Öz; Julie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Eva-Maria Ratai; Nouha Salibi; Tom W J Scheenen; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Franklyn A Howe
Journal:  Magn Reson Med       Date:  2019-03-28       Impact factor: 4.668

2.  Automation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.

Authors:  SoHyun Han; Radka Stoyanova; Hansol Lee; Sean D Carlin; Jason A Koutcher; HyungJoon Cho; Ellen Ackerstaff
Journal:  Magn Reson Med       Date:  2017-07-20       Impact factor: 4.668

3.  Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.

Authors:  Radka Stoyanova; Kris Huang; Kiri Sandler; Hyungjoon Cho; Sean Carlin; Pat B Zanzonico; Jason A Koutcher; Ellen Ackerstaff
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

4.  Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.

Authors:  Sandra Ortega-Martorell; Paulo J G Lisboa; Alfredo Vellido; Rui V Simões; Martí Pumarola; Margarida Julià-Sapé; Carles Arús
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

5.  Data analysis and tissue type assignment for glioblastoma multiforme.

Authors:  Yuqian Li; Yiming Pi; Xin Liu; Yuhan Liu; Sofie Van Cauter
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.